Saturday, July 11, 2026

pharma · Diarrhea-predominant Irritable Bowel Syndrome

Chengdu University of

News and analysis for Chengdu University of on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
256 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
256
Programs
1
Drugs
1
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Chengdu University of — regulatory, clinical, and market coverage.

News and analysis for Chengdu University of on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Chengdu University of yet.

Back to company overview →